1.95 (-%)
As of Jul 29, 2022
Source:
We are a clinical stage biopharmaceutical company focused on novel therapeutic approaches to improve the lives of patients diagnosed with Alzheimer’s and other degenerative diseases. Our company was founded on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic virulence factor proteases, called gingipains, in the relevant brain areas of both Alzheimer's and Parkinson's disease patients.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | 415-910-5717 |
Industry | manufacturing |
CEO | Dirk Thye |
Website | www.quincetx.com |